Jarom Kesler Comments on Ex Parte Review Trends at the USPTO in Bloomberg Law Interview
In an interview with Bloomberg Law, Knobbe Martens partner Jarom Kesler shared his perspective on the latest trends in institution rates of ex parte reviews (EPRs) at the U.S. Patent...
Carol Pitzel Cruz Comments in Law360 on Enablement Analysis in Pharmaceutical Patent Litigation
Knobbe Martens partner Carol Pitzel Cruz was quoted in a recent Law360 article on the Federal Circuit’s decision in Wyeth v. AstraZeneca, a patent infringement dispute centered on Section 112...
Understanding AI and Patent Eligibility
In this episode of Knobbe IP+, Knobbe Martens partners Jarom Kesler and Bryan McWhorter discuss the latest developments in AI and patent eligibility. Sharing insights for both fellow IP practitioners and...